TAOK1 promotes filament formation in HR repair through phosphorylating USP7

Tian-Chen Zhu1,2, Zhang-Ping He3, Shu-Ting Li1,2

  • 1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510000, China.

Insights

Thousand and one amino acid protein kinase 1 (TAOK1) inhibition enhances PARP inhibitor efficacy in cancer. Blocking TAOK1 or its interaction with USP7 degrades RAD51, disrupting DNA repair and increasing cancer cell sensitivity to PARP inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Poly-ADP-ribose polymerase (PARP) inhibitors are key cancer therapies for tumors with homologous recombination (HR) defects.
  • Expanding the clinical use of PARP inhibitors is limited by resistance mechanisms.

Purpose of the Study:

  • To identify novel targets for synthetic lethality with PARP inhibitors.
  • To investigate the role of thousand and one amino acid protein kinase 1 (TAOK1) in DNA damage response and PARP inhibitor resistance.

Main Methods:

  • High-throughput kinase inhibitor screening to find targets synthetically lethal with PARP inhibitors.
  • Genetic depletion and pharmacological inhibition of TAOK1.
  • Assessment of RAD51 stability and HR repair function.
  • Evaluation of cancer cell sensitivity to PARP inhibition.

Main Results:

  • TAOK1 phosphorylates ubiquitin specific peptidase 7 (USP7), enhancing its activity.
  • USP7 activity prevents RAD51 ubiquitylation and degradation, preserving HR repair.
  • Inhibiting TAOK1 or USP7 function leads to RAD51 degradation and HR repair defects.
  • TAOK1 inhibition or USP7 blocking peptides increase cancer cell sensitivity to PARP inhibitors.

Conclusions:

  • TAOK1 is a critical regulator of the HR repair pathway in human cancer cells.
  • Combining PARP inhibitors with TAOK1 inhibition or USP7-targeting peptides offers a strategy to overcome PARPi resistance.
  • This approach holds potential for improving therapeutic outcomes in cancer treatment.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.0K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.9K
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
9.7K
Generation of Straight or Branched Actin Filaments01:14

Generation of Straight or Branched Actin Filaments

The straight or branched structure formation of actin filaments is controlled by nucleating proteins such as the formins and Arp2/3 complex. Formin-mediated assembly results in straight filaments, whereas Arp2/3 protein complex-mediated assembly results in branched actin filaments.
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
2.8K